7 Einträge gefunden

1. Sofosbuvir, velpatasvir, and voxilaprevir for patients with failure of previous direct-acting antiviral therapy for chronic hepatitis C: Results from the German Hepatitis C-Registry (DHC-R)

   1. Vermehren, Johannes
   2. Serfert, Yvonne
   3. Cornberg, Markus
   4. Stoehr, Albrecht
   5. Klinker, Hartwig
   6. Simon, Karl-Georg
   7. Teuber, Gerlinde

   2020 - Forschungsinformationssystem des UKE
2. Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2 dose-finding trial

   1. Traussnigg, Stefan
   2. Schattenberg, Jörn M
   3. Demir, Münevver
   4. Wiegand, Johannes
   5. Geier, Andreas
   6. Teuber, Gerlinde
   7. Hofmann, Wolf Peter

   2019 - Forschungsinformationssystem des UKE
3. Aktuelle Aspekte zur HCV-Triple-Therapie bei Suchtpatienten

   1. Backmund, Markus
   2. Forestier, Nicole
   3. Isernhagen, Konrad
   4. Klinker, Hartwig
   5. Naumann, Uwe
   6. Reimer, Jens
   7. Teuber, Gerlinde

   2012 - Forschungsinformationssystem des UKE
4. Improved responses to pegylated interferon alfa-2b and ribavirin by individualizing treatment for 24-72 weeks.

   1. Sarrazin, Christoph
   2. Schwendy, Susanne
   3. Möller, Bernd
   4. Dikopoulos, Nektarios
   5. Buggisch, Peter
   6. Encke, Jens
   7. Teuber, Gerlinde

   2011 - Forschungsinformationssystem des UKE
5. Individualized treatment strategy according to early viral kinetics in hepatitis C virus type 1-infected patients.

   1. Berg, Thomas
   2. Weich, Viola
   3. Teuber, Gerlinde
   4. Klinker, Hartwig
   5. Möller, Bernd
   6. Rasenack, Jens
   7. Hinrichsen, Holger

   2009 - Forschungsinformationssystem des UKE
6. Placebo-controlled trial of 400 mg amantadine combined with peginterferon alfa-2a and ribavirin for 48 weeks in chronic hepatitis C virus-1 infection.

   1. von Wagner, Michael
   2. Hofmann, Wolf Peter
   3. Teuber, Gerlinde
   4. Berg, Thomas
   5. Goeser, Tobias
   6. Spengler, Ulrich
   7. Hinrichsen, Holger

   2008 - Forschungsinformationssystem des UKE
7. Evaluation of complement factor 5 variants as genetic risk factors for the development of advanced fibrosis in chronic hepatitis C infection.

   1. Halangk, Juliane
   2. Sarrazin, Christoph
   3. Neumann, Konrad
   4. Puhl, Gero
   5. Mueller, Tobias
   6. Teuber, Gerlinde
   7. Klinker, Hartwig

   2008 - Forschungsinformationssystem des UKE